Report Detail
Global Percutaneous Transhepatic Cholangiography Market Report 2018-2029
- RnM3875580 |
- 22 August, 2023 |
- Global |
- 142 Pages |
- HJResearch |
- Medical Devices & Consumables
The Percutaneous Transhepatic Cholangiography (PTC) industry plays a crucial role in diagnosing and treating various biliary pathologies, including jaundice, stone removal, postoperative or posttraumatic bile leakage, and other conditions. PTC is a minimally invasive radiological procedure that involves the injection of contrast material into the biliary system via a percutaneous route to visualize and assess the hepatic and extrahepatic bile ducts. With a projected global market size of US$254 million in 2022 and a compound annual growth rate of 5.8%, the PTC industry is experiencing steady growth and presents significant prospects for the future.
Definition and Use:
Percutaneous Transhepatic Cholangiography is a diagnostic and therapeutic procedure used to evaluate and manage disorders of the biliary system. It involves the insertion of a fine needle through the skin and liver parenchyma into the intrahepatic bile ducts under fluoroscopic guidance. Contrast material is then injected, allowing visualization of the biliary tree and identification of any abnormalities or obstructions. In addition to its diagnostic capabilities, PTC can also be used for therapeutic purposes, such as stone removal or the placement of biliary stents to alleviate obstructions and restore the flow of bile.
Industry Status:
The global Percutaneous Transhepatic Cholangiography market is expected to reach a value of US$254 million in 2022. This growth is driven by several factors contributing to the industry's expansion.
The increasing prevalence of biliary disorders, such as bile duct stones, strictures, and tumors, fuels the demand for PTC procedures. Additionally, advancements in imaging technologies, including improved fluoroscopic guidance and image quality, have enhanced the safety and efficacy of PTC, further driving its adoption.
The acceptance of minimally invasive procedures continues to rise, as PTC offers a less invasive alternative to traditional open surgical approaches. This approach reduces patient discomfort, shortens hospital stays, and results in faster recovery times. Moreover, the growing geriatric population worldwide contributes to increased demand for PTC, as age-related biliary disorders become more prevalent.
Major Manufacturers:
The Percutaneous Transhepatic Cholangiography industry is characterized by the presence of several global manufacturers committed to innovation, product quality, and patient safety. Key players in this market include B. Braun Melsungen AG, KARL STORZ, Cardinal Health, and GE Healthcare. These manufacturers invest significantly in research and development to enhance device performance, develop specialized tools, and improve patient outcomes. By collaborating with healthcare professionals and institutions, these companies ensure the delivery of high-quality products that meet the specific needs of PTC procedures.
Prospects and Opportunities:
The Percutaneous Transhepatic Cholangiography industry presents significant prospects for growth and advancements in the coming years.
Technological Advancements: Ongoing research and development efforts focus on improving imaging techniques, contrast agents, and catheterization tools for enhanced visualization and procedural success rates. Innovations in equipment design and navigation systems contribute to the refinement of PTC procedures.
Therapeutic Applications: Beyond its diagnostic role, PTC offers opportunities for therapeutic interventions. The development of advanced devices and techniques for stone removal, stent placement, and drainage procedures enhances the ability to manage biliary disorders effectively.
Growing Awareness and Adoption: Increasing awareness about the benefits of minimally invasive procedures, coupled with a rising preference for outpatient settings, drives the adoption of PTC. Educational initiatives targeted at healthcare professionals and patients can further boost awareness and promote wider acceptance of PTC as a standard procedure for biliary system evaluation.
Emerging Markets: Developing regions present untapped market opportunities due to improving healthcare infrastructure, growing patient populations, and rising awareness of biliary disorders. Expansion into these markets can contribute to significant growth for manufacturers.
Collaboration and Training: Manufacturers can collaborate with healthcare professionals and institutions to provide training programs for PTC procedures. This would enhance the skills and expertise of medical staff, increase procedural success rates, and drive wider adoption of PTC.
Conclusion:
The Percutaneous Transhepatic Cholangiography industry plays a crucial role in the diagnosis and treatment of biliary disorders. With a projected market size of US$254 million in 2022 and a compound annual growth rate of 5.8%, the industry demonstrates steady growth and promising prospects.
PTC offers a minimally invasive approach to visualize and manage biliary pathologies, providing benefits such as reduced patient discomfort, shorter hospital stays, and faster recovery times. Major manufacturers such as B. Braun Melsungen AG, KARL STORZ, Cardinal Health, and GE Healthcare contribute to innovation and offer a wide range of high-quality devices that meet the specific requirements of PTC procedures.
Technological advancements, therapeutic applications, growing awareness, emerging markets, and collaboration initiatives present significant opportunities for the industry's progress. By focusing on research and development, expanding into new markets, and fostering collaboration with healthcare professionals, the Percutaneous Transhepatic Cholangiography industry can further advance patient care and contribute to the effective management of biliary disorders globally.
The SWOT analysis of the Percutaneous Transhepatic Cholangiography industry is as follows:
Strengths:
Minimally Invasive Procedure: PTC offers a less invasive alternative to traditional open surgical approaches for evaluating and managing biliary disorders. It reduces patient discomfort, shortens hospital stays, and results in faster recovery times.
Diagnostic and Therapeutic Capabilities: PTC serves both diagnostic and therapeutic purposes. It allows visualization and assessment of the biliary system, enabling the identification of abnormalities or obstructions. Additionally, it can be used for stone removal or the placement of biliary stents to alleviate obstructions and restore bile flow.
Advancements in Imaging Technology: The industry has witnessed advancements in imaging technologies, such as improved fluoroscopic guidance and image quality. These advancements enhance the safety and efficacy of PTC procedures, leading to improved patient outcomes.
Key Industry Players: The PTC industry is supported by key manufacturers dedicated to innovation, product quality, and patient safety. These manufacturers invest in research and development to enhance device performance, develop specialized tools, and improve patient outcomes.
Weaknesses:
Procedural Complexity: Performing PTC requires specialized medical expertise and technical skills. The complexity of the procedure may limit its adoption in some healthcare settings where the required resources or trained personnel are lacking.
Potential Complications: While PTC is generally safe, like any medical procedure, it carries potential risks and complications, including bleeding, infection, bile leakage, and damage to surrounding structures. These risks need to be carefully managed and communicated to patients.
Opportunities:
Technological Advancements: Continuous research and development efforts can lead to further technological advancements in PTC procedures. Improvements in imaging techniques, contrast agents, catheterization tools, and navigation systems can enhance visualization and procedural success rates.
Therapeutic Applications: There is an opportunity to expand the therapeutic applications of PTC. Developing advanced devices and techniques for stone removal, stent placement, and drainage procedures can improve the management of biliary disorders.
Increasing Awareness and Acceptance: Educating healthcare professionals and patients about the benefits of PTC and its outcomes compared to traditional surgery can increase awareness and acceptance of the procedure. This can drive its adoption as a standard method for evaluating biliary pathologies.
Threats:
Alternative Diagnostic and Therapeutic Modalities: The availability of alternative diagnostic and therapeutic modalities, such as endoscopic retrograde cholangiopancreatography (ERCP) or magnetic resonance cholangiopancreatography (MRCP), may pose a threat to the widespread adoption of PTC. These alternatives may be considered based on specific patient needs and clinician preferences.
Regulatory Challenges: Stringent regulatory requirements governing medical procedures and device approval processes can impact the development and timely market entry of new PTC technologies. Manufacturers must navigate these regulations effectively to bring innovations to the market.
Economic Factors: Economic fluctuations, reimbursement policies, and healthcare budget constraints can influence the adoption and accessibility of PTC procedures. Economic considerations may affect the willingness of healthcare providers to invest in PTC equipment and the ability of patients to afford the procedure.
Key players in global Percutaneous Transhepatic Cholangiography market include:
B. Braun Melsungen AG
KARL STORZ
Cardinal Health
GE Healthcare
Market segmentation, by product types:
PTC Plastic Pancreatic & Biliary Stenting Procedures
PTC Metal Pancreatic & Biliary Stenting Procedures
Market segmentation, by applications:
Jaundice
Stone Removal
Postoperative or Posttraumatic Bile Leakage
Others
1 Industry Overview of Percutaneous Transhepatic Cholangiography
- 1.1 Research Scope
- 1.2 Market Segmentation by Types of Percutaneous Transhepatic Cholangiography
- 1.3 Market Segmentation by End Users of Percutaneous Transhepatic Cholangiography
- 1.4 Market Dynamics Analysis of Percutaneous Transhepatic Cholangiography
- 1.4.1 Market Drivers
- 1.4.2 Market Challenges
- 1.4.3 Market Opportunities
- 1.4.4 Porter’s Five Forces
2 Major Manufacturers Analysis of Percutaneous Transhepatic Cholangiography Industry
- 2.1 B. Braun Melsungen AG
- 2.1.1 Company Overview
- 2.1.2 Main Products and Specifications
- 2.1.3 Percutaneous Transhepatic Cholangiography Sales Volume, Revenue, Price and Gross Margin (2018-2023)
- 2.1.4 Contact Information
- 2.2 KARL STORZ
- 2.2.1 Company Overview
- 2.2.2 Main Products and Specifications
- 2.2.3 Percutaneous Transhepatic Cholangiography Sales Volume, Revenue, Price and Gross Margin (2018-2023)
- 2.2.4 Contact Information
- 2.3 Cardinal Health
- 2.3.1 Company Overview
- 2.3.2 Main Products and Specifications
- 2.3.3 Percutaneous Transhepatic Cholangiography Sales Volume, Revenue, Price and Gross Margin (2018-2023)
- 2.3.4 Contact Information
- 2.4 GE Healthcare
- 2.4.1 Company Overview
- 2.4.2 Main Products and Specifications
- 2.4.3 Percutaneous Transhepatic Cholangiography Sales Volume, Revenue, Price and Gross Margin (2018-2023)
- 2.4.4 Contact Information
3 Global Percutaneous Transhepatic Cholangiography Market Analysis by Regions, Manufacturers, Types and End Users
- 3.1 Global Sales Volume and Revenue of Percutaneous Transhepatic Cholangiography by Regions (2018-2023)
- 3.2 Global Sales Volume and Revenue of Percutaneous Transhepatic Cholangiography by Manufacturers (2018-2023)
- 3.3 Global Sales Volume and Revenue of Percutaneous Transhepatic Cholangiography by Types (2018-2023)
- 3.4 Global Sales Volume and Revenue of Percutaneous Transhepatic Cholangiography by End Users (2018-2023)
- 3.5 Selling Price Analysis of Percutaneous Transhepatic Cholangiography by Regions, Manufacturers, Types and End Users in (2018-2023)
4 Northern America Percutaneous Transhepatic Cholangiography Market Analysis by Countries, Types and End Users
- 4.1 Northern America Percutaneous Transhepatic Cholangiography Sales Volume and Revenue Analysis by Countries (2018-2023)
- 4.2 Northern America Percutaneous Transhepatic Cholangiography Sales Volume and Revenue Analysis by Types (2018-2023)
- 4.3 Northern America Percutaneous Transhepatic Cholangiography Sales Volume and Revenue Analysis by End Users (2018-2023)
- 4.4 United States Percutaneous Transhepatic Cholangiography Sales Volume, Revenue, Import and Export Analysis (2018-2023)
- 4.5 Canada Percutaneous Transhepatic Cholangiography Sales Volume, Revenue, Import and Export Analysis (2018-2023)
5 Europe Percutaneous Transhepatic Cholangiography Market Analysis by Countries, Types and End Users
- 5.1 Europe Percutaneous Transhepatic Cholangiography Sales Volume and Revenue Analysis by Countries (2018-2023)
- 5.2 Europe Percutaneous Transhepatic Cholangiography Sales Volume and Revenue Analysis by Types (2018-2023)
- 5.3 Europe Percutaneous Transhepatic Cholangiography Sales Volume and Revenue Analysis by End Users (2018-2023)
- 5.4 Germany Percutaneous Transhepatic Cholangiography Sales Volume, Revenue, Import and Export Analysis (2018-2023)
- 5.5 France Percutaneous Transhepatic Cholangiography Sales Volume, Revenue, Import and Export Analysis (2018-2023)
- 5.6 UK Percutaneous Transhepatic Cholangiography Sales Volume, Revenue, Import and Export Analysis (2018-2023)
- 5.7 Italy Percutaneous Transhepatic Cholangiography Sales Volume, Revenue, Import and Export Analysis (2018-2023)
- 5.8 Russia Percutaneous Transhepatic Cholangiography Sales Volume, Revenue, Import and Export Analysis (2018-2023)
- 5.9 Spain Percutaneous Transhepatic Cholangiography Sales Volume, Revenue, Import and Export Analysis (2018-2023)
- 5.10 Netherlands Percutaneous Transhepatic Cholangiography Sales Volume, Revenue, Import and Export Analysis (2018-2023)
6 Asia Pacific Percutaneous Transhepatic Cholangiography Market Analysis by Countries, Types and End Users
- 6.1 Asia Pacific Percutaneous Transhepatic Cholangiography Sales Volume and Revenue Analysis by Countries (2018-2023)
- 6.2 Asia Pacific Percutaneous Transhepatic Cholangiography Sales Volume and Revenue Analysis by Types (2018-2023)
- 6.3 Asia Pacific Percutaneous Transhepatic Cholangiography Sales Volume and Revenue Analysis by End Users (2018-2023)
- 6.4 China Percutaneous Transhepatic Cholangiography Sales Volume, Revenue, Import and Export Analysis (2018-2023)
- 6.5 Japan Percutaneous Transhepatic Cholangiography Sales Volume, Revenue, Import and Export Analysis (2018-2023)
- 6.6 Korea Percutaneous Transhepatic Cholangiography Sales Volume, Revenue, Import and Export Analysis (2018-2023)
- 6.7 India Percutaneous Transhepatic Cholangiography Sales Volume, Revenue, Import and Export Analysis (2018-2023)
- 6.8 Australia Percutaneous Transhepatic Cholangiography Sales Volume, Revenue, Import and Export Analysis (2018-2023)
- 6.9 Indonesia Percutaneous Transhepatic Cholangiography Sales Volume, Revenue, Import and Export Analysis (2018-2023)
- 6.10 Vietnam Percutaneous Transhepatic Cholangiography Sales Volume, Revenue, Import and Export Analysis (2018-2023)
7 Latin America Percutaneous Transhepatic Cholangiography Market Analysis by Countries, Types and End Users
- 7.1 Latin America Percutaneous Transhepatic Cholangiography Sales Volume and Revenue Analysis by Countries (2018-2023)
- 7.2 Latin America Percutaneous Transhepatic Cholangiography Sales Volume and Revenue Analysis by Types (2018-2023)
- 7.3 Latin America Percutaneous Transhepatic Cholangiography Sales Volume and Revenue Analysis by End Users (2018-2023)
- 7.4 Brazil Percutaneous Transhepatic Cholangiography Sales Volume, Revenue, Import and Export Analysis (2018-2023)
- 7.5 Mexico Percutaneous Transhepatic Cholangiography Sales Volume, Revenue, Import and Export Analysis (2018-2023)
- 7.6 Argentina Percutaneous Transhepatic Cholangiography Sales Volume, Revenue, Import and Export Analysis (2018-2023)
- 7.7 Colombia Percutaneous Transhepatic Cholangiography Sales Volume, Revenue, Import and Export Analysis (2018-2023)
8 Middle East & Africa Percutaneous Transhepatic Cholangiography Market Analysis by Countries, Types and End Users
- 8.1 Middle East & Africa Percutaneous Transhepatic Cholangiography Sales Volume and Revenue Analysis by Countries (2018-2023)
- 8.2 Middle East & Africa Percutaneous Transhepatic Cholangiography Sales Volume and Revenue Analysis by Types (2018-2023)
- 8.3 Middle East & Africa Percutaneous Transhepatic Cholangiography Sales Volume and Revenue Analysis by End Users (2018-2023)
- 8.4 Turkey Percutaneous Transhepatic Cholangiography Sales Volume, Revenue, Import and Export Analysis (2018-2023)
- 8.5 Saudi Arabia Percutaneous Transhepatic Cholangiography Sales Volume, Revenue, Import and Export Analysis (2018-2023)
- 8.6 South Africa Percutaneous Transhepatic Cholangiography Sales Volume, Revenue, Import and Export Analysis (2018-2023)
- 8.7 Egypt Percutaneous Transhepatic Cholangiography Sales Volume, Revenue, Import and Export Analysis (2018-2023)
9 Marketing Channel, Distributors and Traders Analysis
- 9.1 Marketing Channel
- 9.1.1 Direct Channel
- 9.1.2 Indirect Channel
- 9.2 Distributors and Traders
10 Global Percutaneous Transhepatic Cholangiography Market Forecast by Regions, Countries, Manufacturers, Types and End Users
- 10.1 Global Sales Volume and Revenue Forecast of Percutaneous Transhepatic Cholangiography by Regions (2024-2029)
- 10.2 Global Sales Volume and Revenue Forecast of Percutaneous Transhepatic Cholangiography by Types (2024-2029)
- 10.3 Global Sales Volume and Revenue Forecast of Percutaneous Transhepatic Cholangiography by End Users (2024-2029)
- 10.4 Global Revenue Forecast of Percutaneous Transhepatic Cholangiography by Countries (2024-2029)
- 10.4.1 United States Revenue Forecast (2024-2029)
- 10.4.2 Canada Revenue Forecast (2024-2029)
- 10.4.3 Germany Revenue Forecast (2024-2029)
- 10.4.4 France Revenue Forecast (2024-2029)
- 10.4.5 UK Revenue Forecast (2024-2029)
- 10.4.6 Italy Revenue Forecast (2024-2029)
- 10.4.7 Russia Revenue Forecast (2024-2029)
- 10.4.8 Spain Revenue Forecast (2024-2029)
- 10.4.9 Netherlands Revenue Forecast (2024-2029)
- 10.4.10 China Revenue Forecast (2024-2029)
- 10.4.11 Japan Revenue Forecast (2024-2029)
- 10.4.12 Korea Revenue Forecast (2024-2029)
- 10.4.13 India Revenue Forecast (2024-2029)
- 10.4.14 Australia Revenue Forecast (2024-2029)
- 10.4.15 Indonesia Revenue Forecast (2024-2029)
- 10.4.16 Vietnam Revenue Forecast (2024-2029)
- 10.4.17 Brazil Revenue Forecast (2024-2029)
- 10.4.18 Mexico Revenue Forecast (2024-2029)
- 10.4.19 Argentina Revenue Forecast (2024-2029)
- 10.4.20 Colombia Revenue Forecast (2024-2029)
- 10.4.21 Turkey Revenue Forecast (2024-2029)
- 10.4.22 Saudi Arabia Revenue Forecast (2024-2029)
- 10.4.23 South Africa Revenue Forecast (2024-2029)
- 10.4.24 Egypt Revenue Forecast (2024-2029)
11 Industry Chain Analysis of Percutaneous Transhepatic Cholangiography
- 11.1 Upstream Major Raw Materials and Equipment Suppliers Analysis of Percutaneous Transhepatic Cholangiography
- 11.1.1 Major Raw Materials Suppliers with Contact Information Analysis of Percutaneous Transhepatic Cholangiography
- 11.1.2 Major Equipment Suppliers with Contact Information Analysis of Percutaneous Transhepatic Cholangiography
- 11.2 Downstream Major Consumers Analysis of Percutaneous Transhepatic Cholangiography
- 11.3 Major Suppliers of Percutaneous Transhepatic Cholangiography with Contact Information
- 11.4 Supply Chain Relationship Analysis of Percutaneous Transhepatic Cholangiography
12 Percutaneous Transhepatic Cholangiography New Project Investment Feasibility Analysis
- 12.1 Percutaneous Transhepatic Cholangiography New Project SWOT Analysis
- 12.2 Percutaneous Transhepatic Cholangiography New Project Investment Feasibility Analysis
- 12.2.1 Project Name
- 12.2.2 Investment Budget
- 12.2.3 Project Product Solutions
- 12.2.4 Project Schedule
13 Percutaneous Transhepatic Cholangiography Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.2 References and Data Sources
- 14.2.1 Primary Sources
- 14.2.2 Secondary Paid Sources
- 14.2.3 Secondary Public Sources
- 14.3 Abbreviations and Units of Measurement
- 14.4 Author Details
Summary:
Get latest Market Research Reports on Percutaneous Transhepatic Cholangiography. Industry analysis & Market Report on Percutaneous Transhepatic Cholangiography is a syndicated market report, published as Global Percutaneous Transhepatic Cholangiography Market Report 2018-2029. It is complete Research Study and Industry Analysis of Percutaneous Transhepatic Cholangiography market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
